Adicet Bio's market cap is currently ―. The company's EPS TTM is $-3.319; its P/E ratio is -0.68; Adicet Bio is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-0.44. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 179.00K	$ 179.00K	$ 179.00K	-	$ 0.00
Gross Profit	$ 179.00K	$ 179.00K	$ 179.00K	-	-
EBIT	$ -49.88M	$ -32.40M	$ -30.86M	$ -32.03M	$ -21.98M
EBITDA	$ -48.28M	$ -30.89M	$ -29.55M	$ -33.83M	$ -21.22M
Net Income Common Stockholders	$ -10.96M	$ -32.40M	$ -30.88M	$ -29.87M	$ -22.00M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 183.26M	$ 205.46M	$ 231.64M	$ 257.66M	$ 282.68M
Total Assets	$ 233.26M	$ 277.63M	$ 304.97M	$ 330.69M	$ 354.30M
Total Debt	$ 21.80M	$ 22.64M	$ 23.50M	$ 21.02M	$ 21.72M
Net Debt	$ -161.46M	$ -182.82M	$ -208.14M	$ -236.63M	$ -260.96M
Total Liabilities	$ 38.58M	$ 38.57M	$ 38.76M	$ 38.35M	$ 36.65M
Stockholders Equity	$ 194.68M	$ 239.06M	$ 266.21M	$ 292.34M	$ 317.66M
Cash Flow	-
Free Cash Flow	$ -22.14M	$ -26.42M	$ -25.96M	-	$ -20.14M
Operating Cash Flow	$ -21.24M	$ -24.91M	$ -24.05M	-	$ -15.33M
Investing Cash Flow	$ -906.00K	$ -1.51M	$ -1.92M	-	$ -4.81M
Financing Cash Flow	$ -59.00K	$ 226.00K	$ -7.00K	-	$ 42.18M

Currency in USD

Adicet Bio Earnings and Revenue History

Income Statement >

Adicet Bio Debt to Assets

Balance Sheet >

Adicet Bio Cash Flow

Cash Flow >

Adicet Bio Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing